24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
@Finance
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Anchiano
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
20:42
Israel orders hundreds of radar systems designed to detect fiber-optic drones
20:10
Israel aims to build space-based laser weapons, Defense Minister says
17:23
AppsFlyer: “The nature of employee expectations has changed significantly”
16:46
"Data is the fuel of the new world. We must make sure it remains ours."
More stories
Buzz
Most popular
Daily
Weekly
1
Iron Dome and Iron Beam maker Rafael signs $2.3 billion Spyder air defense deal with Romania
2
Mindspace co-founder launches $25 million fund to buy out aging family businesses
3
Wiz co-founder says Google deal feels “like a kid in a candy store”
4
Israel orders hundreds of radar systems designed to detect fiber-optic drones
5
AI solved coding. Now complexity is the bottleneck
More news
Anchiano
2 stories about Anchiano
Anchiano Therapeutics Schedules TASE Delisting
14.03.19
|
Lilach Baumer
Based in Jerusalem and Cambridge, Massachusetts, clinical-stage Anchiano develops gene therapies for cancer, with a special focus on bladder cancer
Cancer Treatment Company Anchiano Therapeutics Wants to List on Nasdaq
09.01.19
|
Lilach Baumer
The company formerly known as BioCanCell submitted a prospectus to the SEC on Monday, with Oppenheimer & Co. as the sole underwriter